Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gas bubble surface tension in the gastrointestinal tract refers to the physical property that maintains the integrity and size of gas bubbles within the stomach and intestines. Elevated surface tension makes gas bubbles more resistant to coalescing and dispersing, which can contribute to symptoms such as bloating and pain. Certain medications, most notably simethicone, act as surfactants to reduce this surface tension, leading to the coalescence and breakup of gas bubbles, allowing gas to be expelled more easily and alleviating related symptoms[1][2][4][5][6]. This property is targeted pharmacologically by simethicone and similar agents but does not represent a discrete molecular target or protein[2][4]. This entry is not a canonical therapeutic target but an important concept explaining the action of anti-flatulence remedies.
Reduction of gas bubble surface tension (by physical surfactant action, not biochemical interaction)[1][2][4][5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gas bubble surface tension in gastrointestinal tract.